Establishing clinical performance characteristics for Duoseq, a new assay for DNA and RNA sequencing. The distribution of positivity rates in relation to cancer type and biological samples.

Pathogen detection and surveillance have become a high priority in both healthcare and environmental settings for the safety of patients and the general public. The COVID-19 pandemic highlighted the ...

"I’m not seeing any function in your daughter’s kidney," the doctor stated. "There are several cysts." These were the words that came out of my doctor’s mouth during my 20-week anatomy ultrasound.

New next generation sequencing (NGS) technologies that can examine millions of DNA variants at a time and help inform treatment decisions are at the heart of two new draft guidance documents released ...

The Human Genome Project began over thirty years ago, taking more than thirteen years and 2.7 billion dollars to complete. Much of that hefty price tag came in the form of a genomics-inspired ...

Advancements in next-generation sequencing (NGS) technologies have enabled researchers to generate genome-wide data of unprecedented quality and quantity. Genomics, expression, microRNA, chromatin IP, ...

Expansion of QIAseq portfolio to Long Read Panels enables high-resolution analysis of complex genomic regions using long-read sequencing Supports NGS platforms such as PacBio (PACB) for applications ...

Even the most straightforward next-generation sequencing (NGS) experiments can be expensive and time-consuming. Thus, it’s a good idea to test your workflow on a few samples to make sure you’ll get ...

[more than 13% of patients with advanced NSCLC and an aSV] "would have experienced a meaningful delay of several weeks or more if RNA-NGS and DNA-NGS had been performed sequentially rather than ...